First Infliximab Biosimilar Approved in Brazil For Crohn’s Disease
Crohn's Disease, News
The National Health Surveillance Agency (ANVISA) in Brazil has approved the commercialization of Remsima (infliximab), indicated for a series of conditions such as Crohn’s disease and ulcerative colitis, making it the first ... Read more